Jeremy’s work in ZS’s emerging biopharma practice focuses on various facets of marketing strategy, including opportunity assessment, positioning, segmentation and forecasting. He has spent his career on marketing and sales issues in the pharmaceutical and biotech industries.

Jeremy has deep expertise in portfolio strategy, new product development, and early commercialization. He is experienced in driving a range of high impact, strategic initiatives. He has helped clients make hundreds of “go/no go” clinical development decisions, and has enabled dozens of launches across a wide range of therapy areas. Jeremy has significant expertise in CNS, ophthalmology, dermatology and consumer-driven medical markets.

Before joining ZS in 2009, Jeremy worked for Johnson & Johnson and Neurocrine Biosciences and as a consultant with Trinity Partners. 

Jeremy holds an MBA from the Fuqua School of Business at Duke University, with a concentration in health sector management, and an A.B. from Harvard University.